TrialJournal of viral hepatitis2023

A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI-2173 in patients with chronic hepatitis B virus infection.

Katherine E Squires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.